Home › Funds › Velan Capital Investment Management LP › ANTX

Velan Capital Investment Management LP position in ANTX

AN2 THERAPEUTICS INC · Health Care

Velan Capital Investment Management LP reported holding 40,000 shares of ANTX (AN2 THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$213K, representing 0.20% of its reported portfolio and ranking #31 among its reported holdings. Velan Capital Investment Management LP has disclosed ANTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)40.00K sh
Reported value held$212.80K
Portfolio Weight0.20%
First reportedQ2 2026
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Velan Capital Investment Management LP's ANTX position evolved

Velan Capital Investment Management LP first disclosed a stake in ANTX in Q2 2026 at 40,000 shares (US$194K). The position peaked in Q3 2026 at 40,000 shares, worth US$213K. Across 2 filings, Velan Capital Investment Management LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 40,000 shares valued at US$213K.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 40.00K $193.60K New
Q3 2026 40.00K $212.80K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANTX and 13F data

ANTX (AN2 THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in ANTX — the largest reported positions include Vivo Capital, LLC (US$16.8M), Commodore Capital LP (US$14.2M), Spruce Street Capital LP (US$9.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANTX

All ANTX fund holders →

FAQ

How long has Velan Capital Investment Management LP held ANTX?

Velan Capital Investment Management LP has disclosed ANTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Velan Capital Investment Management LP's current position in ANTX?

As of Q3 2026, Velan Capital Investment Management LP holds 40.00K shares of ANTX (AN2 THERAPEUTICS INC), valued at $212.80K, representing 0.20% of its reported portfolio and ranking #31.

Has Velan Capital Investment Management LP been buying or selling ANTX?

In the latest 13F filing (Q3 2026), Velan Capital Investment Management LP held unchanged its position in ANTX. The position peaked in Q3 2026 at 40.00K shares.

Which other funds hold ANTX?

Other major institutional holders of ANTX include Vivo Capital, LLC, Commodore Capital LP, Spruce Street Capital LP, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.